POST-MARKETING SURVEILLANCE OF NEW DRUGS .1. REVIEW OF OBJECTIVES AND METHODOLOGY

被引：33

作者：

WARDELL, WM ^{[1
]}

TSIANCO, MC ^{[1
]}

ANAVEKAR, SN ^{[1
]}

DAVIS, HT ^{[1
]}

机构：

[1] UNIV ROCHESTER,MED CTR,CTR STUDY DRUG DEV,DEPT BIOSTAT,ROCHESTER,NY 14642

来源：

关键词：

D O I：

10.1002/j.1552-4604.1979.tb02464.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：85 / 94

页数：10

共 16 条

[1] BLACKWELL B, 1975, CLIN PHARMACOL THER, V18, P653
[2] COHEN J, 1967, STATISTICAL POWER AN
[3] RECOGNITION OF UNWANTED DRUG EFFECTS
DOLL, R
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5649): : 69 - +
[4] ORAL-CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE .1. PROSPECTIVE AND RETROSPECTIVE STUDIES
DRILL, VA
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 219 (05) : 583 - +
[5] EVANS DP, 1976, THESIS U LONDON
[6] FEINSTEIN AR, 1973, CLIN PHARMACOL THER, V14, P291
[7] FLEISS JL, 1973, STATISTICAL METHODS
[8] Friedman G, 1974, PRIMER EPIDEMIOLOGY
[9] MacMahon B., 1960, EPIDEMIOLOGIC METHOD
[10] REMINGTON RD, 1976, 7TH ANN M AM SOC CLI